Increased sensitivity of mice to tremorogenic agents following MPP+

Area of Science:

• Neuroscience
• Neurotoxicology
• Behavioral Pharmacology

Background:

• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin implicated in Parkinsonism.
• MPTP is metabolized to MPP+, which selectively damages dopaminergic neurons.
• Understanding MPP+'s behavioral effects is crucial for Parkinson's disease research.

Purpose of the Study:

• To evaluate the behavioral consequences of intrastriatal MPP+ administration in mice.
• To investigate MPP+-induced changes in striatal dopamine levels and conditioned avoidance behavior.
• To assess the impact of MPP+ on cholinergic system sensitivity and tremor.

Main Methods:

• Mice were trained in a shuttle box paradigm.
• Bilateral intrastriatal injections of MPP+ (10 micrograms) were administered.
• Behavioral assessments included conditioned avoidance responding, rotorod performance, and oxotremorine challenge.

Main Results:

• MPP+ injection led to a 66% decrease in striatal dopamine.
• Significant deficits in conditioned avoidance responding were observed.
• MPP+-treated mice showed increased sensitivity to oxotremorine-induced motor impairments and tremor.

Conclusions:

• Intrastriatal MPP+ induces significant motor and behavioral deficits in mice.
• MPP+ treatment results in dopaminergic neurotoxicity and cholinergic hypersensitivity.
• These findings contribute to understanding the neurobiological basis of idiopathic parkinsonism.